DBV Technologies S.A.
Montrouge, France, March 5, 2021
DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021.
A webcast of the presentation at the H.C. Wainwright Healthcare Conference will be available on the Investors & Media section of the Company’s website beginning Tuesday, March 9th at 7:00 a.m. ET: https://www.dbv-technologies.com/investor-relations/.
About DBV Technologies
DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, DBV’s method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients. DBV’s food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France and offices in Bagneux, France, and North American operations in Summit, NJ and New York, NY. The Company’s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), and the Company’s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).
Investor Contact
Anne Pollak
DBV Technologies
+1 857-529-2363
anne.pollak@dbv-technologies.com
Media Contact
Angela Marcucci
DBV Technologies
+1 646-842-2393
angela.marcucci@dbv-technologies.com
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Netbet Enterprises Limited16.4.2024 12:23:48 CEST | Pressemeddelelse
NetBet Casino slår sig sammen med Play'n Go
Netbet Enterprises Limited16.4.2024 12:23:37 CEST | Press release
NetBet Casino joins forces with Play'n Go
Netbet Enterprises Limited12.4.2024 12:56:15 CEST | Press release
NetBet Casino joins forces with Nolimit City
Netbet Enterprises Limited12.4.2024 12:56:15 CEST | Pressemeddelelse
NetBet Casino slår sig sammen med Nolimit City
Netbet Enterprises Limited9.4.2024 11:26:32 CEST | Press release
NetBet Casino joins forces with G Games
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom